These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 16634702

  • 1. Emerging drugs for the treatment of chronic obstructive pulmonary disease.
    Malhotra S, Man SF, Sin DD.
    Expert Opin Emerg Drugs; 2006 May; 11(2):275-91. PubMed ID: 16634702
    [Abstract] [Full Text] [Related]

  • 2. Emerging drugs for chronic obstructive pulmonary disease.
    Matera MG, Calzetta L, Segreti A, Cazzola M.
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):61-82. PubMed ID: 22335427
    [Abstract] [Full Text] [Related]

  • 3. Future Advances in COPD Therapy.
    Barnes PJ.
    Respiration; 2001 Mar; 68(5):441-8. PubMed ID: 11694802
    [Abstract] [Full Text] [Related]

  • 4. Development of new drugs for COPD.
    Barnes PJ.
    Curr Med Chem; 2013 Mar; 20(12):1531-40. PubMed ID: 22963554
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Advances in the management of chronic obstructive pulmonary disease.
    Meinke L, Chitkara R, Krishna G.
    Expert Opin Pharmacother; 2007 Jan; 8(1):23-37. PubMed ID: 17163804
    [Abstract] [Full Text] [Related]

  • 12. New treatments for chronic obstructive pulmonary disease.
    Barnes PJ.
    Ann Ist Super Sanita; 2003 Jan; 39(4):573-82. PubMed ID: 15098577
    [Abstract] [Full Text] [Related]

  • 13. Chemokines and chemokine receptors blockers as new drugs for the treatment of chronic obstructive pulmonary disease.
    Caramori G, Di Stefano A, Casolari P, Kirkham PA, Padovani A, Chung KF, Papi A, Adcock IM.
    Curr Med Chem; 2013 Jan; 20(35):4317-49. PubMed ID: 24059236
    [Abstract] [Full Text] [Related]

  • 14. Potential role of leukotriene modifiers in the treatment of chronic obstructive pulmonary disease.
    Usery JB, Self TH, Muthiah MP, Finch CK.
    Pharmacotherapy; 2008 Sep; 28(9):1183-7. PubMed ID: 18752388
    [Abstract] [Full Text] [Related]

  • 15. New therapies for chronic obstructive pulmonary disease.
    Barnes PJ.
    Med Princ Pract; 2010 Sep; 19(5):330-8. PubMed ID: 20639653
    [Abstract] [Full Text] [Related]

  • 16. The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications.
    Tamimi A, Serdarevic D, Hanania NA.
    Respir Med; 2012 Mar; 106(3):319-28. PubMed ID: 22196881
    [Abstract] [Full Text] [Related]

  • 17. Emerging pharmacotherapies for COPD.
    Barnes PJ.
    Chest; 2008 Dec; 134(6):1278-1286. PubMed ID: 19059958
    [Abstract] [Full Text] [Related]

  • 18. Clinical Pharmacology of Oral Maintenance Therapies for Obstructive Lung Diseases.
    Pleasants RA.
    Respir Care; 2018 Jun; 63(6):671-689. PubMed ID: 29794203
    [Abstract] [Full Text] [Related]

  • 19. Frontrunners in novel pharmacotherapy of COPD.
    Barnes PJ.
    Curr Opin Pharmacol; 2008 Jun; 8(3):300-7. PubMed ID: 18457992
    [Abstract] [Full Text] [Related]

  • 20. Mucociliary dysfunction in COPD: effect of current pharmacotherapeutic options.
    Rogers DF.
    Pulm Pharmacol Ther; 2005 Jun; 18(1):1-8. PubMed ID: 15607121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.